Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pawelec

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Immunology Letters|September 1, 1989
Regulation of normal myelopoiesis and chronic myelogenous leukaemia cell proliferation through a non-cytotoxic mechanism by a gamma/delta T cell cloneG Pawelec, T Sayers, F W Busch
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clonesG Pawelec, E M Schneider, P Wernet
European Journal of Immunology|February 1, 1985
Function of alloproliferative T lymphocyte clones correlates better with their class II recognitive specificity than with their cell surface phenotypeG Pawelec, E M Schneider, P Wernet
Mechanisms of Ageing and Development|June 8, 2001
Age-related accumulation of oxidative DNA damage and alterations in levels of p16(INK4a/CDKN2a), p21(WAF1/CIP1/SDI1) and p27(KIP1) in human CD4+ T cell clones in vitroP Hyland, C Barnett, G Pawelec, et al.
Immunology Today|September 1, 1995
Immunosenescence: ageing of the immune systemG Pawelec, M Adibzadeh, H Pohla, et al.
Immunology Letters|May 1, 1982
Cloned human T-cell lines with allospecific or natural killer-like cytotoxicityG Pawelec, M Hadam, C Müller, et al.
International Journal of Immunopharmacology|January 1, 1991
CD4+ TCR alpha beta+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clonesO Bruserud, W Hamann, S Patel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinosideG Pawelec, H Schmidt, A Rehbein, et al.
Experimental Gerontology|August 5, 1999
T cell immunosenescence in vitro and in vivoG Pawelec, W Wagner, M Adibzadeh, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2001
The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cellsS Heinzel, D Rea, R Offringa, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Immunology Letters|September 1, 1989
Regulation of normal myelopoiesis and chronic myelogenous leukaemia cell proliferation through a non-cytotoxic mechanism by a gamma/delta T cell cloneG Pawelec, T Sayers, F W Busch
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clonesG Pawelec, E M Schneider, P Wernet
European Journal of Immunology|February 1, 1985
Function of alloproliferative T lymphocyte clones correlates better with their class II recognitive specificity than with their cell surface phenotypeG Pawelec, E M Schneider, P Wernet
Mechanisms of Ageing and Development|June 8, 2001
Age-related accumulation of oxidative DNA damage and alterations in levels of p16(INK4a/CDKN2a), p21(WAF1/CIP1/SDI1) and p27(KIP1) in human CD4+ T cell clones in vitroP Hyland, C Barnett, G Pawelec, et al.
Immunology Today|September 1, 1995
Immunosenescence: ageing of the immune systemG Pawelec, M Adibzadeh, H Pohla, et al.
Immunology Letters|May 1, 1982
Cloned human T-cell lines with allospecific or natural killer-like cytotoxicityG Pawelec, M Hadam, C Müller, et al.
International Journal of Immunopharmacology|January 1, 1991
CD4+ TCR alpha beta+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clonesO Bruserud, W Hamann, S Patel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinosideG Pawelec, H Schmidt, A Rehbein, et al.
Experimental Gerontology|August 5, 1999
T cell immunosenescence in vitro and in vivoG Pawelec, W Wagner, M Adibzadeh, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2001
The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cellsS Heinzel, D Rea, R Offringa, et al.
Pageof 23